World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
57
Citations
10833
World Ranking
2156
National Ranking
46

Rosa Marina Melillo publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Rosa Marina Melillo sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 112 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Rosa Marina Melillo D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Rosa Marina Melillo sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Rosa Marina Melillo is affiliated with the University of Naples Federico II in Italy. Their research primarily spans biochemistry, genetics, molecular biology, and medicine, with a focus on molecular biology, oncology, immunology, cancer research, and pharmacology.

The scientist's recent publications reflect an emphasis on cancer biology, immunotherapy, and inflammatory processes within the tumor microenvironment. Notable papers include:

  • PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells, 2021, Journal of Experimental & Clinical Cancer Research
  • In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies, 2022, Journal for ImmunoTherapy of Cancer
  • Probiotic Lactobacillus rhamnosus GG ( LGG ) restrains the angiogenic potential of colorectal carcinoma cells by activating a proresolving program via formyl peptide receptor 1, 2022, Molecular Oncology
  • Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines, 2022, Cancers
  • The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression, 2022, Cancers

Their frequent coauthors include Federica Liotti, Nella Prevete, Maria Marotta, Daniela Sorriento, and Caterina Ieranò.

Publications by Rosa Marina Melillo are concentrated in several journals with multiple contributions to Cancers, Journal of Experimental & Clinical Cancer Research, and Biomedicine & Pharmacotherapy, among others.

The main research topics covered by their work include:

  • Protein Tyrosine Phosphatases
  • S100 Proteins and Annexins
  • Immune Response and Inflammation
  • Galectins and Cancer Biology
  • Cancer Immunotherapy and Biomarkers
  • Inflammatory mediators and NSAID effects
  • Cancer Cells and Metastasis

Best Publications

  • PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

    Michele Grieco;Massimo Santoro;Maria Teresa Berlingieri;Rosa Marina Melillo

  • Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27 Kip1 by PKB/Akt-mediated phosphorylation in breast cancer

    Giuseppe Viglietto;Maria Letizia Motti;Paola Bruni;Rosa Marina Melillo

  • Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

    M Santoro;F Carlomagno;I D Hay;M A Herrmann

  • The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

    Rosa Marina Melillo;Maria Domenica Castellone;Valentina Guarino;Valentina De Falco

  • HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.

    Monica Fedele;Rosa Visone;Ivana De Martino;Giancarlo Troncone

  • Thyroid cancer and inflammation.

    Valentina Guarino;Maria Domenica Castellone;Elvira Avilla;Rosa Marina Melillo

  • RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.

    Massimo Santoro;Rosa Marina Melillo;Alfredo Fusco

  • Mast cells have a protumorigenic role in human thyroid cancer.

    R M Melillo;V Guarino;E Avilla;M R Galdiero

  • Minireview: RET: normal and abnormal functions.

    Massimo Santoro;Rosa Marina Melillo;Francesca Carlomagno;Giancarlo Vecchio

  • Molecular mechanisms of RET activation in human cancer.

    Massimo Santoro;Rosa Marina Melillo;Francesca Carlomagno;Alfredo Fusco

  • A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma

    Giuliana Salvatore;Tito Claudio Nappi;Paolo Salerno;Yuan Jiang

  • Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8–Akt–Slug pathway

    C Visciano;F Liotti;N Prevete;G Cali

  • BRAF is a therapeutic target in aggressive thyroid carcinoma.

    Giuliana Salvatore;Valentina De Falco;Paolo Salerno;Tito Claudio Nappi

  • Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas

    Maria D Castellone;Valentina Guarino;Valentina De Falco;Francesca Carlomagno

  • Docking Protein FRS2 Links the Protein Tyrosine Kinase RET and Its Oncogenic Forms with the Mitogen-Activated Protein Kinase Signaling Cascade

    R. M. Melillo;M. Santoro;S.-H. Ong;M. Billaud

  • The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line.

    Massimo Santoro;Rosa Marina Melillo;Michele Grieco;Maria Teresa Berlingieri

  • Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret.

    M. Chiariello;R. Visconti;F. Carlomagno;R. M. Melillo

  • Molecular heterogeneity of RET loss of function in Hirschsprung's disease.

    F Carlomagno;G De Vita;M T Berlingieri;V de Franciscis

  • Biological Role and Potential Therapeutic Targeting of the Chemokine Receptor CXCR4 in Undifferentiated Thyroid Cancer

    Valentina De Falco;Valentina Guarino;Elvira Avilla;Maria Domenica Castellone

  • Efficient Inhibition of RET/Papillary Thyroid Carcinoma Oncogenic Kinases by 4-Amino-5-(4-Chloro-Phenyl)-7-(t-Butyl)Pyrazolo[3,4-d]Pyrimidine (PP2)

    Francesca Carlomagno;Donata Vitagliano;Teresa Guida;Fulvio Basolo

Frequent Co-Authors

Alfredo Fusco
Alfredo Fusco University of Naples Federico II
Massimo Santoro
Massimo Santoro University of Padua
Massimo Santoro
Massimo Santoro University of Naples Federico II
Fulvio Basolo
Fulvio Basolo University of Pisa
Gianni Marone
Gianni Marone University of Naples Federico II
Giuseppe Viglietto
Giuseppe Viglietto Magna Graecia University
Paolo Miccoli
Paolo Miccoli University of Pisa
Renato Franco
Renato Franco University of Campania "Luigi Vanvitelli"
Monica Fedele
Monica Fedele National Research Council (CNR)
Amato de Paulis
Amato de Paulis University of Naples Federico II

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring molecular biologists often explore diverse online degree programs to expand their career options. Many students interested in healthcare or laboratory roles consider programs like online direct entry msn programs for non-nurses, which provide a pathway into advanced nursing careers without a prior nursing background. These programs can be particularly valuable for those with a molecular biology foundation who wish to transition into clinical fields quickly.

For those already working as nurses, options like best value nursing education online wgu offer a flexible and affordable route to enhance qualifications. Similarly, professionals looking to advance can benefit from bsn to msn programs online which are designed for working RNs seeking leadership or specialized roles.

When choosing a program, accreditation and reputation are key. Exploring a non profit online university ensures quality education while often providing greater financial value. With these flexible options, graduates in molecular biology can tailor their studies to suit unique career ambitions within the broader life sciences and healthcare sectors.

Best Scientists Citing Rosa Marina Melillo

Trending Scientists

Recently Published Articles